Pub Date : 2024-05-20DOI: 10.24875/recice.m24000449
Gloria Hernández Hernández
{"title":"Clinical evaluation requirements under the new European Union medical device regulation","authors":"Gloria Hernández Hernández","doi":"10.24875/recice.m24000449","DOIUrl":"https://doi.org/10.24875/recice.m24000449","url":null,"abstract":"","PeriodicalId":509332,"journal":{"name":"REC: interventional cardiology (English Edition)","volume":"77 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141123581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-22DOI: 10.24875/recice.m24000442
Manuel Luna-Morales, F. Carrasco-Chinchilla, V. M. Becerra-Muñoz, Juan Alonso-Briales, and, J. Hernández-García
{"title":"Two simultaneous TriClip systems as a bailout technique","authors":"Manuel Luna-Morales, F. Carrasco-Chinchilla, V. M. Becerra-Muñoz, Juan Alonso-Briales, and, J. Hernández-García","doi":"10.24875/recice.m24000442","DOIUrl":"https://doi.org/10.24875/recice.m24000442","url":null,"abstract":"","PeriodicalId":509332,"journal":{"name":"REC: interventional cardiology (English Edition)","volume":"72 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140675340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-15DOI: 10.24875/recice.m24000444
Federico Vergni, Giuliano Fiore, Francesco Pellone, and, Mario Luzi
Assessment of the functional significance of coronary artery stenoses to guide percutaneous coronary intervention is widely performed using pressure wire fractional flow reserve during adenosine-or adenosine triphosphate-induced hyperemia. However, the use of fractional flow reserve may be limited by the contraindications and adverse effects of this hyperemic stimulus, as well as the potential risk of vessel damage from the pressure wire. This review will discuss alternative evaluation methods, including various hyperemic agents, nonhyperemic pressure ratios, and angiography-based indices.
{"title":"Functional assessment of coronary stenosis: alternative hyperemic, nonhyperemic, and angiographic indexes","authors":"Federico Vergni, Giuliano Fiore, Francesco Pellone, and, Mario Luzi","doi":"10.24875/recice.m24000444","DOIUrl":"https://doi.org/10.24875/recice.m24000444","url":null,"abstract":"Assessment of the functional significance of coronary artery stenoses to guide percutaneous coronary intervention is widely performed using pressure wire fractional flow reserve during adenosine-or adenosine triphosphate-induced hyperemia. However, the use of fractional flow reserve may be limited by the contraindications and adverse effects of this hyperemic stimulus, as well as the potential risk of vessel damage from the pressure wire. This review will discuss alternative evaluation methods, including various hyperemic agents, nonhyperemic pressure ratios, and angiography-based indices.","PeriodicalId":509332,"journal":{"name":"REC: interventional cardiology (English Edition)","volume":"38 17","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140701764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-10DOI: 10.24875/recice.m24000454
José Luis Betanzos, A. Alperi, Víctor León, I. Silva, Pablo Avanzas, Isaac Pascual
{"title":"�Edge to edge� transcatheter tricuspid repair for isolated posterior prolapse","authors":"José Luis Betanzos, A. Alperi, Víctor León, I. Silva, Pablo Avanzas, Isaac Pascual","doi":"10.24875/recice.m24000454","DOIUrl":"https://doi.org/10.24875/recice.m24000454","url":null,"abstract":"","PeriodicalId":509332,"journal":{"name":"REC: interventional cardiology (English Edition)","volume":"13 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140717250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-08DOI: 10.24875/recice.m24000445
Carmen Garrote-Coloma, T. Benito, Armando Pérez de Prado, Ignacio Iglesias, María López-Benito, F. Fernández-Vázquez
Heterotopic tricuspid valve implantation is one of the treatment options available for advanced stages of tricuspid regurgitation when other therapeutic possibilities are not feasible. Currently, the TricValve system (P + F Products + Features Vertriebs GmbH, Austria) is one of the most widely used; this system consists of 2 valves that are implanted into the inferior and superior vena cava. Echocardiography plays a significant role during implantation and subsequent monitoring. The echocardiographic assessment of the valve implanted in the inferior vena cava is not difficult by transthoracic (figure 1) or transesophageal echocardiogram; however, the assessment of the superior vena cava is more complex. Therefore, to monitor the superior vena cava, we propose the use of a new view, placing the transthoracic echocardiography transducer on the patient while in the supine position in the suprasternal fossa, between the sternal and clavicular belly of the right sternocleidomastoid muscle (figure 2A, asterisk), with
异位三尖瓣植入术是在三尖瓣反流晚期无法采用其他疗法时的治疗方法之一。目前，TricValve 系统（奥地利 P + F Products + Features Vertriebs GmbH 公司）是应用最广泛的系统之一；该系统由两个瓣膜组成，分别植入下腔静脉和上腔静脉。超声心动图在植入和后续监测过程中发挥着重要作用。通过经胸超声心动图（图 1）或经食道超声心动图对植入下腔静脉的瓣膜进行超声心动图评估并不困难，但对上腔静脉的评估则更为复杂。因此，为了监测上腔静脉，我们建议使用一种新的视角，将经胸超声心动图传感器置于患者仰卧位的胸骨上窝、右胸锁乳突肌的胸骨腹和锁骨腹之间（图 2A，星号），并在患者的胸骨上窝、右胸锁乳突肌的胸骨腹和锁骨腹之间（图 2B，星号）进行监测。
{"title":"A new echocardiographic view for the TricValve system","authors":"Carmen Garrote-Coloma, T. Benito, Armando Pérez de Prado, Ignacio Iglesias, María López-Benito, F. Fernández-Vázquez","doi":"10.24875/recice.m24000445","DOIUrl":"https://doi.org/10.24875/recice.m24000445","url":null,"abstract":"Heterotopic tricuspid valve implantation is one of the treatment options available for advanced stages of tricuspid regurgitation when other therapeutic possibilities are not feasible. Currently, the TricValve system (P + F Products + Features Vertriebs GmbH, Austria) is one of the most widely used; this system consists of 2 valves that are implanted into the inferior and superior vena cava. Echocardiography plays a significant role during implantation and subsequent monitoring. The echocardiographic assessment of the valve implanted in the inferior vena cava is not difficult by transthoracic (figure 1) or transesophageal echocardiogram; however, the assessment of the superior vena cava is more complex. Therefore, to monitor the superior vena cava, we propose the use of a new view, placing the transthoracic echocardiography transducer on the patient while in the supine position in the suprasternal fossa, between the sternal and clavicular belly of the right sternocleidomastoid muscle (figure 2A, asterisk), with","PeriodicalId":509332,"journal":{"name":"REC: interventional cardiology (English Edition)","volume":"52 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140730054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-08DOI: 10.24875/recice.m24000452
Carlos Real, Carlos Ferrera, M. Vázquez-Álvarez, Mike Huanca, Francisco J. Noriega, Enrique Gutierrez-Ibanes, Ana María Mañas-Hernández, Noemí Ramos-López, Miriam Juárez, P. Jiménez-Quevedo, Jaime Elízaga, Ana Viana-Tejedor, Pablo Salinas
Introduction and objectives: Most patients with acute pulmonary embolism (PE) receive anticoagulation only. Reperfusion is required in high-risk and a minority of intermediate-risk PE patients. Systemic thrombolysis (ST) is the first-line reperfusion therapy, but due to contraindications and major bleeding concerns, the use of catheter-directed therapies (CDT) is increasing as a suitable alternative. The objective of the present study was to detect predictors of the use of CDT compared with other therapies in patients with acute PE. Methods: This registry included consecutive intermediate-and high-risk PE patients in 2 tertiary centers with a 24/7 PE response team from 2014 to 2022. The patients were grouped according to the primary treatment: anticoagulation only, CDT, or ST. We evaluated predictors of treatment assignment and safety endpoints. Results: A total of 274 patients were included. Of them, 112 received anticoagulation only, 96 received ST as the primary treatment, and 66 underwent CDT first. Comorbidities were higher in the CDT group than in the other 2 groups. Patients undergoing ST/CDT had higher PE severity parameters at hospital admission. On multivariable analysis, independent predictors for the use of CDT were Charlson Comorbidity Index (OR, 1.29; 95%CI, 1.05-1.59), recent surgery (OR, 11.07; 95%CI, 3.07-39.87), and bilateral central PE (OR, 2.42; 95%CI, 1.10-5.32). Analysis of early safety outcomes showed that intracranial bleeding occurred only in the ST group (1.8% of patients). Conclusions: This contemporary registry used CDT as the primary treatment in 24% of intermediate-and high-risk patients, mainly in comorbid and postsurgical patients. CDT was a safe and effective alternative to medical therapy in selected patients.
引言和目的：大多数急性肺栓塞（PE）患者仅接受抗凝治疗。高危和少数中危 PE 患者需要再灌注治疗。全身溶栓疗法（ST）是一线再灌注疗法，但由于存在禁忌症和大出血问题，导管导向疗法（CDT）作为一种合适的替代疗法的使用率正在上升。本研究旨在检测急性 PE 患者使用 CDT 与其他疗法相比的预测因素。方法：这项登记研究纳入了 2014 年至 2022 年期间在两家拥有全天候 PE 反应团队的三级医疗中心连续就诊的中危和高危 PE 患者。患者根据主要治疗方法分组：仅抗凝、CDT 或 ST。我们评估了治疗分配的预测因素和安全性终点。结果共纳入 274 名患者。其中 112 人仅接受了抗凝治疗，96 人接受了 ST 作为主要治疗方法，66 人首先接受了 CDT。CDT 组的合并症高于其他两组。接受 ST/CDT 治疗的患者入院时的 PE 严重程度参数较高。多变量分析显示，使用 CDT 的独立预测因素包括：Charlson 合并症指数（OR，1.29；95%CI，1.05-1.59）、近期手术（OR，11.07；95%CI，3.07-39.87）和双侧中心性 PE（OR，2.42；95%CI，1.10-5.32）。对早期安全性结果的分析表明，只有 ST 组（1.8% 的患者）发生了颅内出血。结论：这项当代登记研究将 CDT 作为 24% 中高风险患者的主要治疗方法，主要用于合并症患者和手术后患者。对于选定的患者，CDT是一种安全有效的药物治疗替代方法。
{"title":"Reperfusion therapies in patients with intermediateand high-risk pulmonary embolism: insights from a multicenter registry","authors":"Carlos Real, Carlos Ferrera, M. Vázquez-Álvarez, Mike Huanca, Francisco J. Noriega, Enrique Gutierrez-Ibanes, Ana María Mañas-Hernández, Noemí Ramos-López, Miriam Juárez, P. Jiménez-Quevedo, Jaime Elízaga, Ana Viana-Tejedor, Pablo Salinas","doi":"10.24875/recice.m24000452","DOIUrl":"https://doi.org/10.24875/recice.m24000452","url":null,"abstract":"Introduction and objectives: Most patients with acute pulmonary embolism (PE) receive anticoagulation only. Reperfusion is required in high-risk and a minority of intermediate-risk PE patients. Systemic thrombolysis (ST) is the first-line reperfusion therapy, but due to contraindications and major bleeding concerns, the use of catheter-directed therapies (CDT) is increasing as a suitable alternative. The objective of the present study was to detect predictors of the use of CDT compared with other therapies in patients with acute PE. Methods: This registry included consecutive intermediate-and high-risk PE patients in 2 tertiary centers with a 24/7 PE response team from 2014 to 2022. The patients were grouped according to the primary treatment: anticoagulation only, CDT, or ST. We evaluated predictors of treatment assignment and safety endpoints. Results: A total of 274 patients were included. Of them, 112 received anticoagulation only, 96 received ST as the primary treatment, and 66 underwent CDT first. Comorbidities were higher in the CDT group than in the other 2 groups. Patients undergoing ST/CDT had higher PE severity parameters at hospital admission. On multivariable analysis, independent predictors for the use of CDT were Charlson Comorbidity Index (OR, 1.29; 95%CI, 1.05-1.59), recent surgery (OR, 11.07; 95%CI, 3.07-39.87), and bilateral central PE (OR, 2.42; 95%CI, 1.10-5.32). Analysis of early safety outcomes showed that intracranial bleeding occurred only in the ST group (1.8% of patients). Conclusions: This contemporary registry used CDT as the primary treatment in 24% of intermediate-and high-risk patients, mainly in comorbid and postsurgical patients. CDT was a safe and effective alternative to medical therapy in selected patients.","PeriodicalId":509332,"journal":{"name":"REC: interventional cardiology (English Edition)","volume":"196 S566","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140730750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-08DOI: 10.24875/recice.m24000448
José Antonio Sorolla Romero, J. Martínez Solé, Andrea Teira Calderón, María Calvo Asensio, J. L. Diez Gil, Jorge Sanz Sánchez
{"title":"Use of cutting or scoring balloons in patients with native coronary artery disease: systematic review and meta-analysis","authors":"José Antonio Sorolla Romero, J. Martínez Solé, Andrea Teira Calderón, María Calvo Asensio, J. L. Diez Gil, Jorge Sanz Sánchez","doi":"10.24875/recice.m24000448","DOIUrl":"https://doi.org/10.24875/recice.m24000448","url":null,"abstract":"","PeriodicalId":509332,"journal":{"name":"REC: interventional cardiology (English Edition)","volume":"35 32","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140728202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：